<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37950846</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1548-3576</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Current HIV/AIDS reports</Title><ISOAbbreviation>Curr HIV/AIDS Rep</ISOAbbreviation></Journal><ArticleTitle>Update on Central Nervous System Effects of the Intersection of HIV-1 and SARS-CoV-2.</ArticleTitle><Pagination><StartPage>345</StartPage><EndPage>356</EndPage><MedlinePgn>345-356</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11904-023-00676-8</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW">Research has shown myriad neurologic and mental health manifestations during the acute and subsequent stages of COVID-19 in people with HIV (PWH). This review summarizes the updates on central nervous system (CNS) outcomes following SARS-CoV-2 infection in PWH and highlight the existing knowledge gaps in this area.</AbstractText><AbstractText Label="RECENT FINDINGS">Studies leveraging electronic record systems have highlighted the excess risk of developing acute and lingering neurological complications of COVID-19 in PWH compared to people without HIV (PWoH). However, there is a notable scarcity of neuroimaging as well as blood and cerebrospinal fluid (CSF) marker studies that can confirm the potential synergy between these two infections, particularly in PWH receiving suppressive antiretroviral therapy. Considering the unclear potential interaction between SARS-CoV-2 and HIV, clinicians should remain vigilant regarding new-onset or worsening neurological symptoms in PWH following COVID-19, as they could be linked to either infection.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ocampo</LastName><ForeName>Ferron F</ForeName><Initials>FF</Initials><AffiliationInfo><Affiliation>SEARCH Research Foundation, Block 28, 926 Tower C Room C114-C115 Soi Chula 7, Wang Mai, Pathum Wan, Bangkok, 10330, Thailand. ferron.o@searchthailand.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Promsena</LastName><ForeName>Pathariya</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>SEARCH Research Foundation, Block 28, 926 Tower C Room C114-C115 Soi Chula 7, Wang Mai, Pathum Wan, Bangkok, 10330, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence for Pediatric Infectious Diseases and Vaccines, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Phillip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurology, Yale University, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yale Center for Brain and Mind Health, Yale University, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr HIV/AIDS Rep</MedlineTA><NlmUniqueID>101235661</NlmUniqueID><ISSNLinking>1548-3568</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015497" MajorTopicYN="Y">HIV-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="Y">HIV Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006679" MajorTopicYN="Y">HIV Seropositivity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002490" MajorTopicYN="N">Central Nervous System</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">HIV</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">NeuroCOVID</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>13</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>11</Day><Hour>20</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>11</Day><Hour>11</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37950846</ArticleId><ArticleId IdType="doi">10.1007/s11904-023-00676-8</ArticleId><ArticleId IdType="pii">10.1007/s11904-023-00676-8</ArticleId></ArticleIdList><ReferenceList><ReferenceList><Title>Papers of particular interest, published recently, have been highlighted as: &#x2022;&#x2022; Of major importance</Title><Reference><Citation>WHO Coronavirus Disease (COVID-19) Dashboard [Internet]. World Health Organization; [cited 2023 Jun 12]. Available from: https://covid19.who.int/ .</Citation></Reference><Reference><Citation>Bonanad C, Garc&#xed;a-Blas S, Tarazona-Santabalbina F, Sanchis J, Bertomeu-Gonz&#xe1;lez V, F&#xe1;cila L, et al. The effect of age on mortality in patients with COVID-19: A meta-analysis with 611,583 subjects. J Am Med Dir Assoc. 2020;21(7):915&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">32674819</ArticleId><ArticleId IdType="pmc">7247470</ArticleId><ArticleId IdType="doi">10.1016/j.jamda.2020.05.045</ArticleId></ArticleIdList></Reference><Reference><Citation>Aveyard P, Gao M, Lindson N, Hartmann-Boyce J, Watkinson P, Young D, et al. Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study. Lancet Respir Med. 2021;9(8):909&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">33812494</ArticleId><ArticleId IdType="pmc">8016404</ArticleId><ArticleId IdType="doi">10.1016/S2213-2600(21)00095-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Ssentongo P, Ssentongo AE, Heilbrunn ES, Ba DM, Chinchilli VM. Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis. PLoS ONE. 2020;15:e0238215.</Citation><ArticleIdList><ArticleId IdType="pubmed">32845926</ArticleId><ArticleId IdType="pmc">7449476</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0238215</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y, Chen Y, Liu M, Shi S, Tian J. Impacts of immunosuppression and immunodeficiency on COVID-19: A systematic review and meta-analysis. J Infect. 2020;81(2):e93&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">32502509</ArticleId><ArticleId IdType="pmc">7264926</ArticleId><ArticleId IdType="doi">10.1016/j.jinf.2020.05.017</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Notarte KI, Peligro PJ, Velasco JV, Ocampo MJ, Henry BM, et al. Long-COVID symptoms in individuals infected with different SARS-CoV-2 variants of concern: A systematic review of the literature. Viruses. 2022;14(12):2629.</Citation><ArticleIdList><ArticleId IdType="pubmed">36560633</ArticleId><ArticleId IdType="pmc">9785120</ArticleId><ArticleId IdType="doi">10.3390/v14122629</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">34951953</ArticleId><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Dangayach NS, Newcombe V, Sonnenville R. Acute neurologic complications of COVID-19 and postacute sequelae of COVID-19. Crit Care Clin. 2022;38(3):553&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">35667743</ArticleId><ArticleId IdType="pmc">8940578</ArticleId><ArticleId IdType="doi">10.1016/j.ccc.2022.03.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Y, Li X, Zhang L, Wan S, Zhang L, Zhou F. SARS-CoV-2 Omicron variant: recent progress and future perspectives. Signal Transduct Target Ther. 2022;7(1):141.</Citation><ArticleIdList><ArticleId IdType="pubmed">35484110</ArticleId><ArticleId IdType="pmc">9047469</ArticleId><ArticleId IdType="doi">10.1038/s41392-022-00997-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Willett BJ, Grove J, MacLean OA, Wilkie C, De Lorenzo G, Furnon W, et al. SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nat Microbiol. 2022;7(8):1161&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">35798890</ArticleId><ArticleId IdType="pmc">9352574</ArticleId><ArticleId IdType="doi">10.1038/s41564-022-01143-7</ArticleId></ArticleIdList></Reference><Reference><Citation>McCallum M, Czudnochowski N, Rosen LE, Zepeda SK, Bowen JE, Walls AC, et al. Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement. Science. 2022;375(6583):864&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">35076256</ArticleId><ArticleId IdType="pmc">9427005</ArticleId><ArticleId IdType="doi">10.1126/science.abn8652</ArticleId></ArticleIdList></Reference><Reference><Citation>Maslo C, Friedland R, Toubkin M, Laubscher A, Akaloo T, Kama B. Characteristics and outcomes of hospitalized patients in south Africa during the COVID-19 Omicron wave compared with previous waves. JAMA. 2022;327(6):583.</Citation><ArticleIdList><ArticleId IdType="pubmed">34967859</ArticleId><ArticleId IdType="doi">10.1001/jama.2021.24868</ArticleId></ArticleIdList></Reference><Reference><Citation>Stepanova M, Lam B, Younossi E, Felix S, Ziayee M, Price J, et al. The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19. BMC Infect Dis. 2022;22(1):702.</Citation><ArticleIdList><ArticleId IdType="pubmed">35996076</ArticleId><ArticleId IdType="pmc">9394045</ArticleId><ArticleId IdType="doi">10.1186/s12879-022-07657-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Willan J, Agarwal G, Bienz N. Mortality and burden of post-COVID-19 syndrome have reduced with time across SARS-CoV-2 variants in haematology patients. Br J Haematol. 2023;201(4):640&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">36861893</ArticleId><ArticleId IdType="doi">10.1111/bjh.18700</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortellini A, Tabernero J, Mukherjee U, Salazar R, Sureda A, Maluquer C, et al. SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry. Lancet Oncol. 2023;24(4):335&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">36898391</ArticleId><ArticleId IdType="pmc">9991062</ArticleId><ArticleId IdType="doi">10.1016/S1470-2045(23)00056-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiner RC, Collins JK, Team C1F, Murray CJ. Forecasting the trajectory of the COVID-19 pandemic under plausible variant and intervention scenarios: A global modelling study [Internet]. SSRN Journal [cited 2023 Jul 13]. Available from: https://ssrn.com/abstract=4126660 .</Citation></Reference><Reference><Citation>Amanatidou E, Gkiouliava A, Pella E, Serafidi M, Tsilingiris D, Vallianou NG, et al. Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges. Metabolism Open. 2022;14:100180.</Citation><ArticleIdList><ArticleId IdType="pubmed">35313532</ArticleId><ArticleId IdType="pmc">8928742</ArticleId><ArticleId IdType="doi">10.1016/j.metop.2022.100180</ArticleId></ArticleIdList></Reference><Reference><Citation>Zisis SN, Durieux JC, Mouchati C, Perez JA, McComsey GA. The protective effect of coronavirus disease 2019 (COVID-19) vaccination on postacute sequelae of COVID-19: A multicenter study from a large national health research network. Open Forum. Infect Dis. 2022;9(7):ofac228.</Citation></Reference><Reference><Citation>Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. N Engl J Med. 2022;386(15):1397&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pubmed">35172054</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa2118542</ArticleId></ArticleIdList></Reference><Reference><Citation>Najjar-Debbiny R, Gronich N, Weber G, Khoury J, Amar M, Stein N, et al. Effectiveness of Paxlovid in reducing severe coronavirus disease 2019 and mortality in high-risk patients. Clin Infect Dis. 2023;76(3):e342&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">35653428</ArticleId><ArticleId IdType="doi">10.1093/cid/ciac443</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Choi T, Al-Aly Z. Association of treatment with nirmatrelvir and the risk of post&#x2013;COVID-19 condition. JAMA Intern Med. 2023;183(6):554&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">36951829</ArticleId><ArticleId IdType="pmc">10037200</ArticleId><ArticleId IdType="doi">10.1001/jamainternmed.2023.0743</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Anglin K, Durstenfeld MS, Martin JN, Kelly JD, Hsue PY, et al. Effect of oral Nirmatrelvir on long COVID symptoms: 4 cases and rationale for systematic studies. Pathog Immun. 2022;7(1):95&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">35800257</ArticleId><ArticleId IdType="pmc">9254867</ArticleId></ArticleIdList></Reference><Reference><Citation>Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic [Internet]. World Health Organization; [cited 2023 Jun 28]. Available from: https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic</Citation></Reference><Reference><Citation>Chou SH, Beghi E, Helbok R, Moro E, Sampson J, Altamirano V, et al. Global incidence of neurological manifestations among patients hospitalized with COVID-19-a report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium. JAMA Netw Open. 2021;4(5):e2112131.</Citation><ArticleIdList><ArticleId IdType="pubmed">33974053</ArticleId><ArticleId IdType="pmc">8114143</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.12131</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S, Nath A. Nervous system consequences of COVID-19. Science. 2022;375(6578):267&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">35050660</ArticleId><ArticleId IdType="doi">10.1126/science.abm2052</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T. Neurological infection with SARS-CoV-2 - the story so far. Nat Rev Neurol. 2021;17(2):65&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">33414554</ArticleId><ArticleId IdType="pmc">7789883</ArticleId><ArticleId IdType="doi">10.1038/s41582-020-00453-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Misra S, Kolappa K, Prasad M, Radhakrishnan D, Thakur KT, Solomon T, et al. Frequency of neurologic manifestations in COVID-19: a systematic review and meta-analysis. Neurology. 2021;97(23):e2269&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">34635561</ArticleId><ArticleId IdType="pmc">8665434</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000012930</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of Coronavirus disease 2019: A review. JAMA Neurol. 2020;77(8):1018.</Citation><ArticleIdList><ArticleId IdType="pubmed">32469387</ArticleId><ArticleId IdType="pmc">7484225</ArticleId><ArticleId IdType="doi">10.1001/jamaneurol.2020.2065</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604(7907):697&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pubmed">35255491</ArticleId><ArticleId IdType="pmc">9046077</ArticleId><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamasak B, Ulcay T, Nisari M, Gorgulu O, Akca V, Alpaslan M, et al. Effects of COVID-19 on brain and cerebellum: a voxel based morphometrical analysis. Bratisl Lek Listy. 2023;124(6):442&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">36876379</ArticleId></ArticleIdList></Reference><Reference><Citation>Paolini M, Palladini M, Mazza MG, Colombo F, Vai B, Rovere-Querini P, et al. Brain correlates of subjective cognitive complaints in COVID-19 survivors: A multimodal magnetic resonance imaging study. Eur Neuropsychopharmacol. 2023;68:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">36640728</ArticleId><ArticleId IdType="doi">10.1016/j.euroneuro.2022.12.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Campion JY, Dudouet P, Kaphan E, Bregeon F, Tissot-Dupont H, et al. 18F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. 2021;48(9):2823&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">33501506</ArticleId><ArticleId IdType="pmc">7837643</ArticleId><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Goehringer F, Bruyere A, Doyen M, Bevilacqua S, Charmillon A, Heyer S, et al. Brain 18F-FDG PET imaging in outpatients with post-COVID-19 conditions: findings and associations with clinical characteristics. Eur J Nucl Med Mol Imaging. 2023;50(4):1084&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">36322190</ArticleId><ArticleId IdType="doi">10.1007/s00259-022-06013-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkataramani V, Winkler F. Cognitive deficits in long COVID-19. N Engl J Med. 2022;387(19):1813&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">36351274</ArticleId><ArticleId IdType="doi">10.1056/NEJMcibr2210069</ArticleId></ArticleIdList></Reference><Reference><Citation>Zicari S, Sessa L, Cotugno N, Ruggiero A, Morrocchi E, Concato C, et al. Immune activation, inflammation, and non-AIDS co-morbidities in HIV-infected patients under long-term ART. Viruses. 2019;11(3):200.</Citation><ArticleIdList><ArticleId IdType="pubmed">30818749</ArticleId><ArticleId IdType="pmc">6466530</ArticleId><ArticleId IdType="doi">10.3390/v11030200</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourcher V, Gourmelen J, Bureau I, Bouee S. Comorbidities in people living with HIV: an epidemiologic and economic analysis using a claims database in France. PLoS One. 2020;15(12):e0243529.</Citation><ArticleIdList><ArticleId IdType="pubmed">33332394</ArticleId><ArticleId IdType="pmc">7746269</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0243529</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Valero I, Ellis R, Heaton R, Deutsch R, Franklin D, Clifford DB, et al. Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects. AIDS. 2019;33(3):475&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">30702516</ArticleId><ArticleId IdType="doi">10.1097/QAD.0000000000002074</ArticleId></ArticleIdList></Reference><Reference><Citation>Winston A, Spudich S. Cognitive disorders in people living with HIV. Lancet HIV. 2020;7(7):e504&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">32621876</ArticleId><ArticleId IdType="doi">10.1016/S2352-3018(20)30107-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin LH, Maki PM. HIV, depression, and cognitive impairment in the era of effective antiretroviral therapy. Curr HIV/AIDS Rep. 2019;16(1):82&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">30661180</ArticleId><ArticleId IdType="pmc">6420829</ArticleId><ArticleId IdType="doi">10.1007/s11904-019-00421-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso A, Barnes AE, Guest JL, Shah A, Shao IY, Marconi V. HIV infection and incidence of cardiovascular diseases: an analysis of a large healthcare database. J Am Heart Assoc. 2019;8(14):e012241.</Citation><ArticleIdList><ArticleId IdType="pubmed">31266386</ArticleId><ArticleId IdType="pmc">6662120</ArticleId><ArticleId IdType="doi">10.1161/JAHA.119.012241</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of Coronavirus disease 2019: A review. JAMA Neurol. 2020;77(8):1018&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">32469387</ArticleId><ArticleId IdType="pmc">7484225</ArticleId><ArticleId IdType="doi">10.1001/jamaneurol.2020.2065</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad SJ, Feigen CM, Vazquez JP, Kobets AJ, Altschul DJ. Neurological sequelae of COVID-19. J Integr Neurosci. 2022;21(3):77.</Citation><ArticleIdList><ArticleId IdType="pubmed">35633158</ArticleId><ArticleId IdType="doi">10.31083/j.jin2103077</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E, Xie Y, Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat Med. 2022;28(11):2406&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">36138154</ArticleId><ArticleId IdType="pmc">9671811</ArticleId><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Hellmuth J, Chow FC. Central nervous system effects of COVID-19 in people with HIV infection. Curr HIV/AIDS Rep. 2021;18(6):538&#x2013;48. This is a pioneer review article released during the initial stages of the pandemic that summarized the interaction of HIV and SARS-CoV-2 in the CNS.</Citation><ArticleIdList><ArticleId IdType="pubmed">34843065</ArticleId><ArticleId IdType="pmc">8628487</ArticleId><ArticleId IdType="doi">10.1007/s11904-021-00582-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertagnolio S, Thwin SS, Silva R, Nagarajan S, Jassat W, Fowler R, et al. Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19. The Lancet HIV. 2022;9(7):e486&#x2013;95. This multi-country study from the WHO Global Clinical Platform of COVID-19 described the clinical features and risk factors of severe/fatal COVID-19 in PWH who are hospitalized due to COVID-19.</Citation><ArticleIdList><ArticleId IdType="pubmed">35561704</ArticleId><ArticleId IdType="pmc">9090268</ArticleId><ArticleId IdType="doi">10.1016/S2352-3018(22)00097-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, AAR A. Long COVID in people living with HIV. Curr Opin HIV AIDS. 2023;18(3):126&#x2013;34. This is a recent review article which summarized the latest knowledge and highlighted the potential contributors to long COVID in PWH.</Citation><ArticleIdList><ArticleId IdType="pubmed">37144614</ArticleId><ArticleId IdType="doi">10.1097/COH.0000000000000789</ArticleId></ArticleIdList></Reference><Reference><Citation>Mellor MM, Bast AC, Jones NR, et al. Risk of adverse coronavirus disease 2019 outcomes for people living with HIV. AIDS. 2021;35(04):F1&#x2013;F10.</Citation><ArticleIdList><ArticleId IdType="pubmed">33587448</ArticleId><ArticleId IdType="doi">10.1097/QAD.0000000000002836</ArticleId></ArticleIdList></Reference><Reference><Citation>Dandachi D, Geiger G, Montgomery MW, Karmen-Tuohy S, Golzy M, Antar AAR, et al. Characteristics, comorbidities, and outcomes in a multicenter registry of patients with human immunodeficiency virus and coronavirus disease 2019. Clin Infect Dis. 2020;65212:1&#x2013;9.</Citation></Reference><Reference><Citation>Boulle A, Davies MA, Hussey H, Ismail M, Morden E, Vundle Z, et al. Risk factors for Coronavirus disease 2019 (COVID-19) death in a population cohort study from the Western Cape province. South Africa. Clin Infect Dis. 2021;73(7):e2005&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1198</ArticleId></ArticleIdList></Reference><Reference><Citation>Nachega JB, Kapata N, Sam-Agudu NA, Decloedt EH, Katoto PDMC, Nagu T, et al. Minimizing the impact of the triple burden of COVID-19, tuberculosis and HIV on health services in sub-Saharan Africa. Int J Infect Dis. 2021;113(Suppl 1):S16&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">33757874</ArticleId><ArticleId IdType="pmc">7980520</ArticleId><ArticleId IdType="doi">10.1016/j.ijid.2021.03.038</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidary M, Asadi A, Noorbakhsh N, Dashtbin S, Asadollahi P, Dranbandi A, et al. COVID-19 in HIV-positive patients: A systematic review of case reports and case series. J Clin Lab Anal. 2022;36(4):e24308.</Citation><ArticleIdList><ArticleId IdType="pubmed">35187723</ArticleId><ArticleId IdType="pmc">8993621</ArticleId><ArticleId IdType="doi">10.1002/jcla.24308</ArticleId></ArticleIdList></Reference><Reference><Citation>Pujari S, Gaikwad S, Chitalikar A, Dabhade D, Joshi K, Bele V. Long-coronavirus disease among people living with HIV in western India: An observational study. Immun Inflamm Dis. 2021;9(3):1037&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">34078004</ArticleId><ArticleId IdType="pmc">8239760</ArticleId><ArticleId IdType="doi">10.1002/iid3.467</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzitelli M, Trunfio M, Sasset L, Leoni D, Castelli E, Lo Menzo S, et al. Factors associated with severe COVID-19 and post-acute COVID-19 syndrome in a cohort of people living with HIV on antiretroviral treatment and with undetectable HIV RNA. Viruses. 2022;14(3):493.</Citation><ArticleIdList><ArticleId IdType="pubmed">35336900</ArticleId><ArticleId IdType="pmc">8954437</ArticleId><ArticleId IdType="doi">10.3390/v14030493</ArticleId></ArticleIdList></Reference><Reference><Citation>Yendewa G, Perez JA, Patil N, McComsey GA. hiv infection is associated with higher risk of post-acute sequelae of SARS-CoV-2 (PASC) however vaccination is protective. SSRN; cited [2023 Jun 28]. Available from: https://ssrn.com/abstract=4276609 . This work is a multi-center, electronic health record study involving 30,000 PWH that investigated the risk of post-acute sequelae of COVID-19 in PWH across different SARS-CoV-2 variants.</Citation></Reference><Reference><Citation>Bongomin F, Sereke SG, Okot J, Katsigazi R, Kandole TK, Oriekot A, et al. COVID-19, HIV-associated cryptococcal meningitis, disseminated tuberculosis and acute ischaemic stroke: A fatal foursome. Infect Drug Resist. 2021;14:4167&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">34675561</ArticleId><ArticleId IdType="pmc">8517634</ArticleId><ArticleId IdType="doi">10.2147/IDR.S335711</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulati U, Nanduri AC, Juneja P, Kaufman D, Elrod MG, Kolton CB, et al. Case report: A fatal case of latent melioidosis activated by COVID-19. Am J Trop Med Hyg. 2022;106(4):1170&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">35114640</ArticleId><ArticleId IdType="pmc">8991333</ArticleId><ArticleId IdType="doi">10.4269/ajtmh.21-0689</ArticleId></ArticleIdList></Reference><Reference><Citation>Daodu J, Basuli D, Parikh A. A rare case of AIDS co-infected with COVID-19 presenting with disseminated herpes zoster complicated with CMV and Varicella zoster virus meningoencephalitis. Acta Biomed. 2022;93(6):e2022326.</Citation><ArticleIdList><ArticleId IdType="pubmed">36533755</ArticleId><ArticleId IdType="pmc">9828916</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew S, Kalanad A, Khan MM, Hameed AMA, Sathyapal A, Mohankumar P. Cryptococcal meningoencephalitis in post-COVID period:case series and review of literature. J Med Sci Health. 2022;8(2):166&#x2013;72.</Citation></Reference><Reference><Citation>Bessa PB, Brito AKB, Pereira FR, Silva SQE, Almeida TVR, Almeida AP. Ischemic stroke related to HIV and SARS-COV-2 co-infection: a case report. Rev Soc Bras Med Trop. 2020;53:e20200692.</Citation><ArticleIdList><ArticleId IdType="pubmed">33263692</ArticleId><ArticleId IdType="pmc">7723371</ArticleId><ArticleId IdType="doi">10.1590/0037-8682-0692-2020</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad S, Tayyar R, Risch L, Churchill G, Fares E, Choe M, et al. Encephalopathy and seizure activity in a COVID-19 well controlled HIV patient. IDCases. 2020;21:e00814.</Citation><ArticleIdList><ArticleId IdType="pubmed">32426230</ArticleId><ArticleId IdType="pmc">7228895</ArticleId><ArticleId IdType="doi">10.1016/j.idcr.2020.e00814</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Spinelli MA, Deveau T, Forman CA, Munter SE, Mathur S, et al. Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection. AIDS. 2022;36(12):F7&#x2013;F16.</Citation><ArticleIdList><ArticleId IdType="pubmed">35866847</ArticleId><ArticleId IdType="doi">10.1097/QAD.0000000000003338</ArticleId></ArticleIdList></Reference><Reference><Citation>Sha A, Chen H. Infection routes, invasion mechanisms, and drug inhibition pathways of human coronaviruses on the nervous system. Front Neurosci. 2023;17:1169740.</Citation><ArticleIdList><ArticleId IdType="pubmed">37139519</ArticleId><ArticleId IdType="doi">10.3389/fnins.2023.1169740</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A, Chung JY, Singh M, Yinda CK, et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612(7941):758&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">36517603</ArticleId><ArticleId IdType="pmc">9749650</ArticleId><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, L&#xfc;tgehetmann M, Hagel C, Sperhake JP, Schr&#xf6;der AS, Edler C, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19(11):919&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">33031735</ArticleId><ArticleId IdType="pmc">7535629</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur KT, Miller EH, Glendinning MD, Al-Dalahmah O, Banu MA, Boehme AK, et al. COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital. Brain. 2021;144(9):2696&#x2013;708.</Citation><ArticleIdList><ArticleId IdType="pubmed">33856027</ArticleId><ArticleId IdType="pmc">8083258</ArticleId><ArticleId IdType="doi">10.1093/brain/awab148</ArticleId></ArticleIdList></Reference><Reference><Citation>Salman MA, Mallah SI, Khalid W, Ryan Moran L, Abousedu YAI, Jassim GA. Characteristics of Patients with SARS-CoV-2 Positive Cerebrospinal Fluid: A Systematic Review. Int J Gen Med. 2021;14:10385&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">35002295</ArticleId><ArticleId IdType="pmc">8721017</ArticleId><ArticleId IdType="doi">10.2147/IJGM.S333966</ArticleId></ArticleIdList></Reference><Reference><Citation>Normandin E, Holroyd KB, Collens SI, Shaw BM, Siddle KJ, Adams G, et al. Intrathecal inflammatory responses in the absence of SARS-CoV-2 nucleic acid in the CSF of COVID-19 hospitalized patients. J Neurol Sci. 2021;15(430):120023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.120023</ArticleId></ArticleIdList></Reference><Reference><Citation>Ed&#xe9;n A, Grahn A, Bremell D, Aghvanyan A, Bathala P, Fuchs D, et al. Viral antigen and inflammatory biomarkers in cerebrospinal fluid in patients with COVID-19 infection and neurologic symptoms compared with control participants without infection or neurologic symptoms. JAMA Netw Open. 2022;5(5):e2213253.</Citation><ArticleIdList><ArticleId IdType="pubmed">35604688</ArticleId><ArticleId IdType="pmc">9127556</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.13253</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarius S, Pache F, K&#xf6;rtvelyessy P, Jel&#x10d;i&#x107; I, Stettner M, Franciotta D, et al. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients. J Neuroinflammation. 2022;19(1):19</Citation></Reference><Reference><Citation>Beckman D, Bonillas A, Diniz GB, Ott S, Roh JW, Elizaldi SR, et al. SARS-CoV-2 infects neurons and induces neuroinflammation in a non-human primate model of COVID-19. Cell Rep. 2022;41(5):111573.</Citation><ArticleIdList><ArticleId IdType="pubmed">36288725</ArticleId><ArticleId IdType="pmc">9554328</ArticleId><ArticleId IdType="doi">10.1016/j.celrep.2022.111573</ArticleId></ArticleIdList></Reference><Reference><Citation>Seehusen F, Clark JJ, Sharma P, Bentley EG, Kirby A, Subramaniam K, et al. Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse. Viruses. 2022;14(5):1020.</Citation><ArticleIdList><ArticleId IdType="pubmed">35632761</ArticleId><ArticleId IdType="pmc">9146514</ArticleId><ArticleId IdType="doi">10.3390/v14051020</ArticleId></ArticleIdList></Reference><Reference><Citation>Crunfli F, Carregari VC, Veras FP, Silva LS, Nogueira MH, Antunes ASLM, et al. Morphological, cellular, and molecular basis of brain infection in COVID-19 patients. Proc Natl Acad Sci U S A. 2022;119(35):e2200960119.</Citation><ArticleIdList><ArticleId IdType="pubmed">35951647</ArticleId><ArticleId IdType="pmc">9436354</ArticleId><ArticleId IdType="doi">10.1073/pnas.2200960119</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal S, Farfel JM, Arfanakis K, Al-Harthi L, Shull T, Teppen TL, et al. Brain autopsies of critically ill COVID-19 patients demonstrate heterogeneous profile of acute vascular injury, inflammation and age-linked chronic brain diseases. Acta Neuropathol Commun. 2022;10(1):186.</Citation><ArticleIdList><ArticleId IdType="pubmed">36528671</ArticleId><ArticleId IdType="pmc">9758667</ArticleId><ArticleId IdType="doi">10.1186/s40478-022-01493-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo D, Falasca L, Marchioni L, Tammaro A, Adebanjo GAR, Ippolito G, et al. Neuropathology and inflammatory cell characterization in 10 autoptic COVID-19 brains. Cells. 2021;10(9):2262.</Citation><ArticleIdList><ArticleId IdType="pubmed">34571912</ArticleId><ArticleId IdType="pmc">8469459</ArticleId><ArticleId IdType="doi">10.3390/cells10092262</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E, Bartley CM, Chow RD, Ngo TT, Jiang R, Zamecnik CR, et al. Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms. Cell Rep Med. 2021;2(5):100288.</Citation><ArticleIdList><ArticleId IdType="pubmed">33969321</ArticleId><ArticleId IdType="pmc">8091032</ArticleId><ArticleId IdType="doi">10.1016/j.xcrm.2021.100288</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke C, Ferse C, Kreye J, Reincke SM, Sanchez-Sendin E, Rocco A, et al. High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms. Brain Behav Immun. 2021;93:415&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">33359380</ArticleId><ArticleId IdType="doi">10.1016/j.bbi.2020.12.022</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones BI, Freedman A, Thomas MJ, Villalba-Mendez C, Sathia L, Flanagan D, Francis S, Currie CJ. Comorbid diseases and conditions in people with HIV in the UK. Curr Med Res Opin. 2022;38(2):277&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">34761727</ArticleId><ArticleId IdType="doi">10.1080/03007995.2021.2003671</ArticleId></ArticleIdList></Reference><Reference><Citation>De Michele M, Kahan J, Berto I, Schiavo OG, Iacobucci M, Toni D, et al. Cerebrovascular Complications of COVID-19 and COVID-19 Vaccination. Circ Res. 2022;130(8):1187&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">35420916</ArticleId><ArticleId IdType="pmc">9005103</ArticleId><ArticleId IdType="doi">10.1161/CIRCRESAHA.122.319954</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassiliou AG, Vrettou CS, Keskinidou C, Dimopoulou I, Kotanidou A, Orfanos SE. Endotheliopathy in Acute COVID-19 and Long COVID. Int J Mol Sci. 2023;24(9):8237.</Citation><ArticleIdList><ArticleId IdType="pubmed">37175942</ArticleId><ArticleId IdType="pmc">10179170</ArticleId><ArticleId IdType="doi">10.3390/ijms24098237</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Salazar B, Holwerda M, St&#xfc;dle C, Piragyte I, Mercader N, Engelhardt B, et al. COVID-19 and the vasculature: Current aspects and long-term consequences. Front Cell Dev Biol. 2022;10:824851.</Citation><ArticleIdList><ArticleId IdType="pubmed">35242762</ArticleId><ArticleId IdType="pmc">8887620</ArticleId><ArticleId IdType="doi">10.3389/fcell.2022.824851</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanini G, Selleri V, Roncati L, Coppi F, Nasi M, Farinetti A, et al. Vascular "long COVID": A new vessel disease. Angiology. 2023;18:000331972311532. https://doi.org/10.1177/00033197231153204 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00033197231153204</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">32291094</ArticleId><ArticleId IdType="pmc">7146714</ArticleId><ArticleId IdType="doi">10.1016/j.thromres.2020.04.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin S, Aktar S, Rahman MM, Chowdhury MMH. NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity. Microbes and Infect. 2022;24(1):104913.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2021.104913</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M, Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110(21):3484&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">36288726</ArticleId><ArticleId IdType="pmc">9537254</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deveau TM, Munter SE, Ryder D, Buck A, Beck-Engeser G, et al. Chronic viral coinfections differentially affect the likelihood of developing long COVID. J Clin Invest. 2023;133(3):e163669.</Citation><ArticleIdList><ArticleId IdType="pubmed">36454631</ArticleId><ArticleId IdType="pmc">9888380</ArticleId><ArticleId IdType="doi">10.1172/JCI163669</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A, Vojdani E, Saidara E, Maes M. Persistent SARS-CoV-2 infection, EBV, HHV-6 and other factors may contribute to inflammation and autoimmunity in long COVID. Viruses. 2023;15(2):400.</Citation><ArticleIdList><ArticleId IdType="pubmed">36851614</ArticleId><ArticleId IdType="pmc">9967513</ArticleId><ArticleId IdType="doi">10.3390/v15020400</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Xiang M, Jing H, Wang C, Novakovic VA, Shi J. Damage to endothelial barriers and its contribution to long COVID. Angiogenesis. 2023;27:1&#x2013;18.</Citation></Reference><Reference><Citation>Nataf S, Pays L. Molecular insights into SARS-CoV2-induced alterations of the Gut/Brain axis. Int J Mol Sci. 2021;22(19):10440.</Citation><ArticleIdList><ArticleId IdType="pubmed">34638785</ArticleId><ArticleId IdType="pmc">8508788</ArticleId><ArticleId IdType="doi">10.3390/ijms221910440</ArticleId></ArticleIdList></Reference><Reference><Citation>Gareau MG, Barrett KE. Role of the microbiota-gut-brain axis in postacute COVID syndrome. Am J Physiol Gastrointest Liver Physiol. 2023;324(4):G322.</Citation><ArticleIdList><ArticleId IdType="pubmed">36880667</ArticleId><ArticleId IdType="pmc">10042594</ArticleId><ArticleId IdType="doi">10.1152/ajpgi.00293.2022</ArticleId></ArticleIdList></Reference><Reference><Citation>Katuri A, Bryant J, Heredia A, Makar TK. Role of the inflammasomes in HIV-associated neuroinflammation and neurocognitive disorders. Experimental and Molecular Pathology. 2019;108:64&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">30922769</ArticleId><ArticleId IdType="doi">10.1016/j.yexmp.2019.03.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y, Ren Y, Chen R, Hu J, Ji Y, Yang J, et al. Evaluation of Epstein-Barr virus salivary shedding in HIV/AIDS patients and HAART use: A retrospective cohort study. Virol Sin. 2018;33(3):227&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">29654554</ArticleId><ArticleId IdType="pmc">6178557</ArticleId><ArticleId IdType="doi">10.1007/s12250-018-0028-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Perello R, Vergara A, Monclus E, Jimenez S, Montero M, Saubi N, et al. Cytomegalovirus infection in HIV-infected patients in the era of combination antiretroviral therapy. BMC Infect Dis. BMC Infect Dis. 2019;19(1):1030.</Citation><ArticleIdList><ArticleId IdType="pubmed">31801482</ArticleId><ArticleId IdType="doi">10.1186/s12879-019-4643-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Munawwar A, Singh S. Human herpesviruses as copathogens of HIV infection, their role in HIV transmission, and disease progression. J Lab Physicians. 2016;8(1):5&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">27013807</ArticleId><ArticleId IdType="pmc">4785766</ArticleId><ArticleId IdType="doi">10.4103/0974-2727.176228</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezoh G, Crowther NJ. Deciphering endothelial dysfunction in the HIV-infected population. Adv Exp Med Biol. 2019;1134:193&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pubmed">30919339</ArticleId><ArticleId IdType="doi">10.1007/978-3-030-12668-1_11</ArticleId></ArticleIdList></Reference><Reference><Citation>Marincowitz C, Genis A, Goswami N, De Boever P, Nawrot TS, Strijdom H. Vascular endothelial dysfunction in the wake of HIV and ART. FEBS J. 2019;286(7):1256&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">30220106</ArticleId><ArticleId IdType="doi">10.1111/febs.14657</ArticleId></ArticleIdList></Reference><Reference><Citation>Rich S, Klann E, Bryant V, Richards V, Wijayabahu A, Bryant K, et al. A review of potential microbiome-gut-brain axis mediated neurocognitive conditions in persons living with HIV. Brain, Behavior, &amp; Immunity - Health. 2020;9:100168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2020.100168</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta D, Liu J, Xiong H. The impact of COVID-19 on people living with HIV-1 and HIV-1-associated neurological complications. Viruses. 2023;15(5):1117. This is a recent review on the impact of COVID-19 in PWH and HIV-associated neurological disorders.</Citation><ArticleIdList><ArticleId IdType="pubmed">37243203</ArticleId><ArticleId IdType="pmc">10223371</ArticleId><ArticleId IdType="doi">10.3390/v15051117</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich SS. Immune activation in the central nervous system throughout the course of HIV infection. Curr Opin HIV AIDS. 2016;11(2):226&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">26760827</ArticleId><ArticleId IdType="pmc">4773903</ArticleId><ArticleId IdType="doi">10.1097/COH.0000000000000243</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovacs L, Kress TC, Belin de Chantem&#xe8;le EJ. HIV, combination antiretroviral therapy, and vascular diseases in men and women. JACC: Basic Transl Sci. 2022;7(4):410&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">35540101</ArticleId></ArticleIdList></Reference><Reference><Citation>Opsteen S, Files JK, Fram T, Erdmann N. The role of immune activation and antigen persistence in acute and long COVID. J Investig Med. 2023;71(5):545&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">36879504</ArticleId><ArticleId IdType="pmc">9996119</ArticleId><ArticleId IdType="doi">10.1177/10815589231158041</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M, Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110(21):3484&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">36288726</ArticleId><ArticleId IdType="pmc">9537254</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X, Jiang D, Gao L, Zhou J, Xiao J, Cheng X, et al. Clinical characteristics and predictive value of lower CD4+T cell level in patients with moderate and severe COVID-19: a multicenter retrospective study. BMC Infect Dis. 2021;21(1):57.</Citation><ArticleIdList><ArticleId IdType="pubmed">33435865</ArticleId><ArticleId IdType="pmc">7803000</ArticleId><ArticleId IdType="doi">10.1186/s12879-020-05741-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu R, Yan H, Liu M, Tang L, Kong W, Zhu Z, et al. Brief report: Virologic and immunologic outcomes for HIV patients with Coronavirus disease 2019. J Acquir Immune Defic Syndr. 2021;86(2):213&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">33079905</ArticleId><ArticleId IdType="doi">10.1097/QAI.0000000000002540</ArticleId></ArticleIdList></Reference><Reference><Citation>Calza L, Bon I, Borderi M, Colangeli V, Viale P. No significant effect of COVID-19 on immunological and virological parameters in patients with HIV-1 infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2020;85(1):e6&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">32568768</ArticleId><ArticleId IdType="doi">10.1097/QAI.0000000000002427</ArticleId></ArticleIdList></Reference><Reference><Citation>Ocampo, F, Paudel M, Sacdalan C, Pinyakorn, S, Puttamaswin, S, Srieplienchan, S et al. Characteristics and outcomes of COVID-19 in an early treated HIV cohort in Thailand. In Special issue: Abstracts from CROI2023 conference on retroviruses and opportunistic infections: February 19 to 22, 202; Seattle, WA. Top Antivir Med. 2023;31(2):194. This is a conference abstract which investigated the short-term clinical, immunological, virological and neuropsychiatric outcomes of COVID-19 in an early-treated longitudinal HIV cohort in Thailand.</Citation></Reference><Reference><Citation>Biagianti B, Di Liberto A, Nicol&#xf2; Edoardo A, Lisi I, Nobilia L, de Ferrabonc GD, et al. Cognitive assessment in SARS-CoV-2 patients: A systematic review. Front Aging Neurosci. 2022;14:909661.</Citation><ArticleIdList><ArticleId IdType="pubmed">35847679</ArticleId><ArticleId IdType="pmc">9283975</ArticleId><ArticleId IdType="doi">10.3389/fnagi.2022.909661</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, De Lorenzo R, Magnaghi C, Poletti S, Furlan R, et al. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up. Brain Behav Immun. 2021;94:138&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">33639239</ArticleId><ArticleId IdType="pmc">7903920</ArticleId><ArticleId IdType="doi">10.1016/j.bbi.2021.02.021</ArticleId></ArticleIdList></Reference><Reference><Citation>Dziarski A, Marquez NG, Jamal A, Walch S, Romero A, Araujo-Pereira M, et al. Trajectory of post-COVID neurocognitive recovery in people living with and without HIV. In Special Issue: Abstracts from CROI2023 Conference on Retroviruses and Opportunistic Infections: February 19 to 22, 202; Seattle, WA. Top Antivir Med. 2023;31(2):194&#x2013;5. This is a conference abstract from a prospective observational cohort study which compared neurocognitive test performance 4 months after COVID-19 in PWH versus PWoH as well as in PWH and PWoH who did not acquire SARS-CoV-2 infection.</Citation></Reference><Reference><Citation>Panda PK, Gupta J, Chowdhury SR, Kumar R, Meena AK, Madaan P, et al. Psychological and behavioral impact of lockdown and quarantine measures for COVID-19 pandemic on children, adolescents and caregivers: A systematic review and meta-analysis. J Trop Pediatr. 2021;67(1):fmaa122.</Citation><ArticleIdList><ArticleId IdType="pubmed">33367907</ArticleId><ArticleId IdType="doi">10.1093/tropej/fmaa122</ArticleId></ArticleIdList></Reference><Reference><Citation>Odriozola-Gonz&#xe1;lez P, Planchuelo-G&#xf3;mez &#xc1;, Irurtia MJ, de Luis-Garc&#xed;a R. Psychological effects of the COVID-19 outbreak and lockdown among students and workers of a Spanish university. Psychiatry Res. 2020;290:113108.</Citation><ArticleIdList><ArticleId IdType="pubmed">32450409</ArticleId><ArticleId IdType="pmc">7236679</ArticleId><ArticleId IdType="doi">10.1016/j.psychres.2020.113108</ArticleId></ArticleIdList></Reference><Reference><Citation>Panchal U, Salazar de Pablo G, Franco M, Moreno C, Parellada M, Arango C, et al. The impact of COVID-19 lockdown on child and adolescent mental health: systematic review. Eur Child Adolesc Psychiatry. 2023;32(7):1151&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">34406494</ArticleId><ArticleId IdType="doi">10.1007/s00787-021-01856-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Every-Palmer S, Jenkins M, Gendall P, Hoek J, Beaglehole B, Bell C, et al. Psychological distress, anxiety, family violence, suicidality, and wellbeing in New Zealand during the COVID-19 lockdown: A cross-sectional study. PLoS One. 2020;15(11):e0241658.</Citation><ArticleIdList><ArticleId IdType="pubmed">33147259</ArticleId><ArticleId IdType="pmc">7641386</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0241658</ArticleId></ArticleIdList></Reference><Reference><Citation>Marelli S, Castelnuovo A, Somma A, Castronovo V, Mombelli S, Bottoni D, et al. Impact of COVID-19 lockdown on sleep quality in university students and administration staff. J Neurol. 2021;268(1):8&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">32654065</ArticleId><ArticleId IdType="doi">10.1007/s00415-020-10056-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballivian J, Alcaide ML, Cecchini D, Jones DL, Abbamonte JM, Cassetti I. Impact of COVID-19-related stress and lockdown on mental health among people living with HIV in Argentina. J Acquir Immune Defic Syndr. 2020;85(4):475&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">33136748</ArticleId><ArticleId IdType="doi">10.1097/QAI.0000000000002493</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S, Hou J, Chen Y, Lu Y, Brown L, Operario D. Challenges to HIV care and psychological health during the COVID-19 pandemic among people living with HIV in China. AIDS Behav. 2020;24(10):2764&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">32382824</ArticleId><ArticleId IdType="pmc">7203543</ArticleId><ArticleId IdType="doi">10.1007/s10461-020-02903-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuman Tun&#xe7;el &#xd6;, Pulluk&#xe7;u H, Erdem HA, Kurtaran B, Ta&#x15f;bakan SE, Ta&#x15f;bakan M. COVID-19-related anxiety in people living with HIV: an online cross-sectional study. Turk J Med Sci. 2020;50(8):1792&#x2013;800.</Citation><ArticleIdList><ArticleId IdType="pubmed">32777899</ArticleId><ArticleId IdType="pmc">7775684</ArticleId><ArticleId IdType="doi">10.3906/sag-2006-140</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourmistrova NW, Solomon T, Braude P, Strawbridge R, Carter B. Long-term effects of COVID-19 on mental health: A systematic review. J Affect Disord. 2022;(299):118&#x2013;25.</Citation></Reference><Reference><Citation>Taquet M, Sillett R, Zhu L, Mendel J, Camplisson I, Dercon Q, et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1&#x2008;284&#x2008;437 patients. Lancet Psychiatry. 2022;9(10):815&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">35987197</ArticleId><ArticleId IdType="pmc">9385200</ArticleId><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236&#x2009;379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">33836148</ArticleId><ArticleId IdType="pmc">8023694</ArticleId><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue, Y, Liang, C, Weissman S, Lyu, T, Olatosi, B, Li, X. 12-month consequences in people with HIV/SARS-CoV-2 coinfection: National EHR Cohort. In Special Issue: Abstracts from CROI2023 Conference on Retroviruses and Opportunistic Infections: February 19 to 22, 202; Seattle, WA. Top Antivir Med. 2023;31(2):354. This is a conference abstract from the N3C electronic health record study that compared the 12-month outcomes of COVID-19 in PWH versus PWoH, showing that PWH have higher risks of developing neuropsychological complications after COVID-19.</Citation></Reference><Reference><Citation>Hern&#xe1;ndez-Aceituno A, Garc&#xed;a-Hern&#xe1;ndez A, Larumbe-Zabala E. COVID-19 long-term sequelae: Omicron versus Alpha and Delta variants. Infect Dis Now. 2023;53(5).</Citation></Reference><Reference><Citation>Gottlieb M, Wang RC, Yu H, Spatz ES, Montoy JCC, Rodriguez RM, et al. Severe fatigue and persistent symptoms at 3 months following severe acute respiratory syndrome Coronavirus 2 infections during the pre-delta, delta, and omicron time periods: a multicenter prospective cohort study. Clin Infect Dis. 2023;76(11):1930-1941</Citation></Reference><Reference><Citation>Kahlert CR, Strahm C, G&#xfc;sewell S, Cusini A, Brucher A, Goppel S, et al. Post-acute sequelae after severe acute respiratory syndrome coronavirus 2 infection by viral variant and vaccination status: A multicenter cross-sectional study. Clin Infect Dis. 2023;77(2):194&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">36905145</ArticleId><ArticleId IdType="pmc">10371307</ArticleId><ArticleId IdType="doi">10.1093/cid/ciad143</ArticleId></ArticleIdList></Reference><Reference><Citation>Jassat W, Mudara C, Vika C, Welch R, Arendse T, Dryden M, et al. A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants. Int J Infect Dis. 2023;128:102&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">36587841</ArticleId><ArticleId IdType="pmc">9800016</ArticleId><ArticleId IdType="doi">10.1016/j.ijid.2022.12.036</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HTK, Cornelissen L, Castanares-Zapatero D, De Pauw R, Van Cauteren D, Demarest S, et al. Association between SARS-CoV-2 variants and post COVID-19 condition: findings from a longitudinal cohort study in the Belgian adult population [Internet]. Res Sq; [cited 2023 Jul 01]. https://doi.org/10.21203/rs.3.rs-2765170/v1 .</Citation></Reference><Reference><Citation>Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA, et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. AMA. 2023;329(22):1934&#x2013;1946.</Citation></Reference><Reference><Citation>Lauring AS, Tenforde MW, Chappell JD, Gaglani M, Ginde AA, McNeal T, et al. Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: Prospective observational study. BMJ. 2022;(376):e069761.</Citation></Reference><Reference><Citation>Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">17914061</ArticleId><ArticleId IdType="doi">10.1212/01.WNL.0000287431.88658.8b</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang P, Zhang LY, Tan YY, Chen SD. Links between COVID-19 and Parkinson's disease/Alzheimer's disease: Reciprocal impacts, medical care strategies and underlying mechanisms. Transl Neurodegener. 2023;12(1):5.</Citation><ArticleIdList><ArticleId IdType="pubmed">36717892</ArticleId><ArticleId IdType="pmc">9885419</ArticleId><ArticleId IdType="doi">10.1186/s40035-023-00337-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmati M, Yon DK, Lee SW, Soysal P, Koyanagi A, Jacob L, et al. New-onset neurodegenerative diseases as long-term sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis. J Med Virol. 2023;95(7):e28909.</Citation><ArticleIdList><ArticleId IdType="pubmed">37394783</ArticleId><ArticleId IdType="doi">10.1002/jmv.28909</ArticleId></ArticleIdList></Reference><Reference><Citation>de Erausquin GA, Snyder H, Brugha TS, Seshadri S, Carrillo M, Sagar R, et al. Chronic neuropsychiatric sequelae of SARS-CoV-2: Protocol and methods from the Alzheimer's Association Global Consortium. Alzheimers Dement (N Y). 2022;8(1):e12348.</Citation><ArticleIdList><ArticleId IdType="pubmed">36185993</ArticleId><ArticleId IdType="doi">10.1002/trc2.12348</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>